Alice Kennard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alice Kennard has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Suzanne Rainsford
College of Health and Medicine, Australian National University, Canberra, Australia
6 shared publicationsGirish S. Talaulikar
College of Health and Medicine, Australian National University, Canberra, Australia
3 shared publicationsGirish Talaulikar
College of Health and Medicine Australian National University Canberra Australian Capital Territory Australia
3 shared publicationsNicholas Glasgow
College of Health and Medicine Australian National University Canberra Australian Capital Territory Australia
3 shared publicationsNicholas J. Glasgow
College of Health and Medicine, Australian National University, Canberra, Australia
3 shared publicationsAlice M. Richardson
Statistical Support Network, Australian National University, Canberra, Australia
1 shared publication
Latest Publications
- Open Access
- 30 March 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (6) , 1694-1710
Prospective Study of the Association Between Frailty and Health Care Utilization in Patients With Advanced CKD
- 30 March 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (6) , 1694-1710
Open AccessProspective Study of the Association Between Frailty and Health Care Utilization in Patients With Advanced CKD
- Open Access
- 8 January 2025
- Published by Wiley in Internal Medicine Journal
- Vol. 55 (4) , 599-607
Subjective and objectives measures of frailty among adults with advanced chronic kidney disease: a cross‐sectional analysis of clinician misclassification
Background: Frailty is a recognisable clinical measure of impaired physiological reserve and vulnerability to adverse outcomes that is validated among patients with kidney disease. Practice patterns reveal inconsistent use of objective frailty measures by nephrologists, with clinicians prioritising subjective clinical impressions, possibly risking misclassification and discrimination.Aims: The aim of this study was to examine correlations between subjective and objective measures of frailty in a cohort of patients attending routine nephrologist review.Methods: Eighty‐nine participants attending scheduled review with their primary treating nephrologist (n = 6) were included in cross‐sectional analysis. Measured frailty based on Fried phenotype and subjective clinician impression were assessed for congruence using Pearson's correlation analysis and ĸ statistic. Ordinal logistic regression examined patient demographics associated with perceived frailty. Misclassification was explored using descriptive statistics and contingency table analysis.Results: Frailty and prefrailty were prevalent by both objective and subjective means of assessment with minimal correlation between clinician impression and measured Fried phenotype (r = 0.50, P = 0.00, ĸ = 0.25, P = 0.00). Subjective clinician impression misclassified half of participants, influenced by surrogate frailty measures including female sex, comorbidity and reliance on a walking aid. Clinicians were equally likely to over‐classify prefrailty as to under‐recognise established frailty, with no evidence of systemic misclassification bias. Subjective clinican impression of frailty had a positive predictive value of 19.1% and a negative predictive value of 56.2%.Conclusions: Nephrologists' reliance on subjective clinical impressions that overlook or misclassify prefrailty offers incomplete prognostic assessment and potentially misses opportunities for early intervention.
- 8 January 2025
- Published by Wiley in Internal Medicine Journal
- Vol. 55 (4) , 599-607
Open AccessSubjective and objectives measures of frailty among adults with advanced chronic kidney disease: a cross‐sectional analysis of clinician misclassification
Background: Frailty is a recognisable clinical measure of impaired physiological reserve and vulnerability to adverse outcomes that is validated among patients with kidney disease. Practice patterns reveal inconsistent use of objective frailty measures by nephrologists, with clinicians prioritising subjective clinical impressions, possibly risking misclassification and discrimination.Aims: The aim of this study was to examine correlations between subjective and objective measures of frailty in a cohort of patients attending routine nephrologist review.Methods: Eighty‐nine participants attending scheduled review with their primary treating nephrologist (n = 6) were included in cross‐sectional analysis. Measured frailty based on Fried phenotype and subjective clinician impression were assessed for congruence using Pearson's correlation analysis and ĸ statistic. Ordinal logistic regression examined patient demographics associated with perceived frailty. Misclassification was explored using descriptive statistics and contingency table analysis.Results: Frailty and prefrailty were prevalent by both objective and subjective means of assessment with minimal correlation between clinician impression and measured Fried phenotype (r = 0.50, P = 0.00, ĸ = 0.25, P = 0.00). Subjective clinician impression misclassified half of participants, influenced by surrogate frailty measures including female sex, comorbidity and reliance on a walking aid. Clinicians were equally likely to over‐classify prefrailty as to under‐recognise established frailty, with no evidence of systemic misclassification bias. Subjective clinican impression of frailty had a positive predictive value of 19.1% and a negative predictive value of 56.2%.Conclusions: Nephrologists' reliance on subjective clinical impressions that overlook or misclassify prefrailty offers incomplete prognostic assessment and potentially misses opportunities for early intervention.
- Open Access
Longitudinal frailty assessment in the prediction of survival among patients with advanced chronic kidney disease: a prospective observational single-centre cohort study
Objectives This study aims to describe the prevalence, characteristics and longitudinal changes in frailty among outpatient chronic kidney disease (CKD) and haemodialysis (HD) populations and their impact on survival. Design Prospective observational cohort study. Setting Single-centre ambulatory tertiary care setting, metropolitan Australian teaching hospital. Participants Adult patients with advanced CKD (defined as estimated glomerular filtration rate Interventions Fried frailty assessment at baseline, 6 months and 12 months of longitudinal follow-up. Primary outcomes All-cause mortality and kidney transplantation events. Results Frailty was identified in 36.3% of the 256 participants, while an additional 46.5% exhibited prefrailty. Frailty was equally common among CKD and HD cohorts. Frailty outperformed age, comorbidity and laboratory parameters in predicting mortality risk with HR 2.83 (95% CI 1.44 to 5.56, pConclusions Frailty is highly prevalent and closely aligned with survival outcomes. Frailty among patients attending routine outpatient care may demonstrate responsiveness to intervention with subsequent improvements in mortality and other patient-level outcomes.
Open AccessLongitudinal frailty assessment in the prediction of survival among patients with advanced chronic kidney disease: a prospective observational single-centre cohort study
Objectives This study aims to describe the prevalence, characteristics and longitudinal changes in frailty among outpatient chronic kidney disease (CKD) and haemodialysis (HD) populations and their impact on survival. Design Prospective observational cohort study. Setting Single-centre ambulatory tertiary care setting, metropolitan Australian teaching hospital. Participants Adult patients with advanced CKD (defined as estimated glomerular filtration rate Interventions Fried frailty assessment at baseline, 6 months and 12 months of longitudinal follow-up. Primary outcomes All-cause mortality and kidney transplantation events. Results Frailty was identified in 36.3% of the 256 participants, while an additional 46.5% exhibited prefrailty. Frailty was equally common among CKD and HD cohorts. Frailty outperformed age, comorbidity and laboratory parameters in predicting mortality risk with HR 2.83 (95% CI 1.44 to 5.56, pConclusions Frailty is highly prevalent and closely aligned with survival outcomes. Frailty among patients attending routine outpatient care may demonstrate responsiveness to intervention with subsequent improvements in mortality and other patient-level outcomes.
- Open Access
- 13 September 2024
- Published by Springer Nature in BMC Nephrology
- Vol. 25 (1) , 1-12
Patient perspectives and preferences for rehabilitation among people living with frailty and chronic kidney disease: a qualitative evaluation
Background: Understanding the patient perspective of frailty is critical to offering holistic patient-centred care. Rehabilitation strategies for patients with advanced chronic kidney disease (CKD) and frailty are limited in their ability to overcome patient-perceived barriers to participation, resulting in high rates of drop-out and non-adherence. The aim of this study was to explore patient perspectives and preferences regarding experiences with rehabilitation to inform a CKD/Frailty rehabilitation model. Methods: This qualitative study involved two focus groups, six individual semi-structured interviews and three caregiver semi-structured interviews with lived experience of advanced kidney disease and frailty. Interviews were recorded, transcribed, and coded for meaningful concepts and analysed using inductive thematic analysis using constant comparative method of data analysis employing Social Cognitive Theory. Results: Six major themes emerged including accommodating frailty is an act of resilience, exercise is endorsed for rehabilitation but existing programs have failed to meet end-users’ needs. Rehabilitation goals were framed around return to normative behaviours and rehabilitation should have a social dimension, offering understanding for “people like us”. Participants reported on barriers and disruptors to frailty rehabilitation in the CKD context. Participants valued peer-to-peer education, the camaraderie of socialisation and the benefit of feedback for maintaining motivation. Patients undertaking dialysis described the commodity of time and the burden of unresolved symptoms as barriers to participation. Participants reported difficulty envisioning strategies for frailty rehabilitation, maintaining a focus on the immediate and avoidance of future uncertainty. Conclusions: Frailty rehabilitation efforts in CKD should leverage shared experiences, address comorbidity and symptom burden and focus on goals with normative value.
- 13 September 2024
- Published by Springer Nature in BMC Nephrology
- Vol. 25 (1) , 1-12
Open AccessPatient perspectives and preferences for rehabilitation among people living with frailty and chronic kidney disease: a qualitative evaluation
Background: Understanding the patient perspective of frailty is critical to offering holistic patient-centred care. Rehabilitation strategies for patients with advanced chronic kidney disease (CKD) and frailty are limited in their ability to overcome patient-perceived barriers to participation, resulting in high rates of drop-out and non-adherence. The aim of this study was to explore patient perspectives and preferences regarding experiences with rehabilitation to inform a CKD/Frailty rehabilitation model. Methods: This qualitative study involved two focus groups, six individual semi-structured interviews and three caregiver semi-structured interviews with lived experience of advanced kidney disease and frailty. Interviews were recorded, transcribed, and coded for meaningful concepts and analysed using inductive thematic analysis using constant comparative method of data analysis employing Social Cognitive Theory. Results: Six major themes emerged including accommodating frailty is an act of resilience, exercise is endorsed for rehabilitation but existing programs have failed to meet end-users’ needs. Rehabilitation goals were framed around return to normative behaviours and rehabilitation should have a social dimension, offering understanding for “people like us”. Participants reported on barriers and disruptors to frailty rehabilitation in the CKD context. Participants valued peer-to-peer education, the camaraderie of socialisation and the benefit of feedback for maintaining motivation. Patients undertaking dialysis described the commodity of time and the burden of unresolved symptoms as barriers to participation. Participants reported difficulty envisioning strategies for frailty rehabilitation, maintaining a focus on the immediate and avoidance of future uncertainty. Conclusions: Frailty rehabilitation efforts in CKD should leverage shared experiences, address comorbidity and symptom burden and focus on goals with normative value.
- Open Access
- 29 December 2023
- Published by Elsevier in Kidney International Reports
- Vol. 9 (4) , 791-806
Narrative Review: Clinical Implications and Assessment of Frailty in Patients With Advanced CKD
- 29 December 2023
- Published by Elsevier in Kidney International Reports
- Vol. 9 (4) , 791-806
Open AccessNarrative Review: Clinical Implications and Assessment of Frailty in Patients With Advanced CKD
- Open Access
- 21 July 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1-16
Use of frailty assessment instruments in nephrology populations: a scoping review
Background: Frailty is a clinical syndrome of accelerated aging associated with adverse outcomes. Frailty is prevalent among patients with chronic kidney disease but is infrequently assessed in clinical settings, due to lack of consensus regarding frailty definitions and diagnostic tools. This study aimed to review the practice of frailty assessment in nephrology populations and evaluate the context and timing of frailty assessment. Methods: The search included published reports of frailty assessment in patients with chronic kidney disease, undergoing dialysis or in receipt of a kidney transplant, published between January 2000 and November 2021. Medline, CINAHL, Embase, PsychINFO, PubMed and Cochrane Library databases were examined. A total of 164 articles were included for review. Results: We found that studies were most frequently set within developed nations. Overall, 161 studies were frailty assessments conducted as part of an observational study design, and 3 within an interventional study. Studies favoured assessment of participants with chronic kidney disease (CKD) and transplant candidates. A total of 40 different frailty metrics were used. The most frequently utilised tool was the Fried frailty phenotype. Frailty prevalence varied across populations and research settings from 2.8% among participants with CKD to 82% among patients undergoing haemodialysis. Studies of frailty in conservatively managed populations were infrequent (N = 4). We verified that frailty predicts higher rates of adverse patient outcomes. There is sufficient literature to justify future meta-analyses. Conclusions: There is increasing recognition of frailty in nephrology populations and the value of assessment in informing prognostication and decision-making during transitions in care. The Fried frailty phenotype is the most frequently utilised assessment, reflecting the feasibility of incorporating objective measures of frailty and vulnerability into nephrology clinical assessment. Further research examining frailty in low and middle income countries as well as first nations people is required. Future work should focus on interventional strategies exploring frailty rehabilitation.
- 21 July 2023
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1-16
Open AccessUse of frailty assessment instruments in nephrology populations: a scoping review
Background: Frailty is a clinical syndrome of accelerated aging associated with adverse outcomes. Frailty is prevalent among patients with chronic kidney disease but is infrequently assessed in clinical settings, due to lack of consensus regarding frailty definitions and diagnostic tools. This study aimed to review the practice of frailty assessment in nephrology populations and evaluate the context and timing of frailty assessment. Methods: The search included published reports of frailty assessment in patients with chronic kidney disease, undergoing dialysis or in receipt of a kidney transplant, published between January 2000 and November 2021. Medline, CINAHL, Embase, PsychINFO, PubMed and Cochrane Library databases were examined. A total of 164 articles were included for review. Results: We found that studies were most frequently set within developed nations. Overall, 161 studies were frailty assessments conducted as part of an observational study design, and 3 within an interventional study. Studies favoured assessment of participants with chronic kidney disease (CKD) and transplant candidates. A total of 40 different frailty metrics were used. The most frequently utilised tool was the Fried frailty phenotype. Frailty prevalence varied across populations and research settings from 2.8% among participants with CKD to 82% among patients undergoing haemodialysis. Studies of frailty in conservatively managed populations were infrequent (N = 4). We verified that frailty predicts higher rates of adverse patient outcomes. There is sufficient literature to justify future meta-analyses. Conclusions: There is increasing recognition of frailty in nephrology populations and the value of assessment in informing prognostication and decision-making during transitions in care. The Fried frailty phenotype is the most frequently utilised assessment, reflecting the feasibility of incorporating objective measures of frailty and vulnerability into nephrology clinical assessment. Further research examining frailty in low and middle income countries as well as first nations people is required. Future work should focus on interventional strategies exploring frailty rehabilitation.
- Open Access
- 6 March 2023
- Published by Springer Nature in Research Square
Use of frailty assessment instruments in nephrology populations: a scoping review
Background Frailty is a clinical syndrome of accelerated aging associated with adverse outcomes. Frailty is prevalent among patients with chronic kidney disease but is infrequently assessed in clinical settings, due to lack of consensus regarding frailty definitions and diagnostic tools. This study aimed to review the practice of frailty assessment in nephrology populations and evaluate the context and timing of frailty assessment. Methods The search included published reports of frailty assessment in patients with chronic kidney disease, undergoing dialysis or in receipt of a kidney transplant, published between January 2000 and November 2021. Medline, CINAHL, Embase, PsychINFO, PubMed and Cochrane Library databases were examined. A total of 164 articles were included for review. Results We found that studies were most frequently set within developed nations and adopted an observational study design, with paucity of interventional research. Studies favoured assessment of participants with chronic kidney disease (CKD) and transplant candidates. A total of 40 different frailty metrics were used. The most frequently utilised tool was the Fried Frailty Phenotype. Frailty prevalence varied across populations and research settings from 2.8% among participants with CKD to 82% among patients undergoing haemodialysis. Frailty was infrequently examined in conservatively managed populations. We verified that frailty predicts higher rates of adverse patient outcomes. There is sufficient literature to justify future meta-analyses. Conclusions There is increasing recognition of frailty in nephrology populations and the value of assessment in informing prognostication and decision-making during transitions in care. The Fried Frailty Phenotype is frequently utilised and offers comparison of frailty prevalence and outcomes over different research settings, as well as offering the opportunity to define a pre-frail state. Further research examining frailty in culturally and linguistically diverse populations is required. Future work should focus on interventional strategies exploring frailty rehabilitation.
- 6 March 2023
- Published by Springer Nature in Research Square
Open AccessUse of frailty assessment instruments in nephrology populations: a scoping review
Background Frailty is a clinical syndrome of accelerated aging associated with adverse outcomes. Frailty is prevalent among patients with chronic kidney disease but is infrequently assessed in clinical settings, due to lack of consensus regarding frailty definitions and diagnostic tools. This study aimed to review the practice of frailty assessment in nephrology populations and evaluate the context and timing of frailty assessment. Methods The search included published reports of frailty assessment in patients with chronic kidney disease, undergoing dialysis or in receipt of a kidney transplant, published between January 2000 and November 2021. Medline, CINAHL, Embase, PsychINFO, PubMed and Cochrane Library databases were examined. A total of 164 articles were included for review. Results We found that studies were most frequently set within developed nations and adopted an observational study design, with paucity of interventional research. Studies favoured assessment of participants with chronic kidney disease (CKD) and transplant candidates. A total of 40 different frailty metrics were used. The most frequently utilised tool was the Fried Frailty Phenotype. Frailty prevalence varied across populations and research settings from 2.8% among participants with CKD to 82% among patients undergoing haemodialysis. Frailty was infrequently examined in conservatively managed populations. We verified that frailty predicts higher rates of adverse patient outcomes. There is sufficient literature to justify future meta-analyses. Conclusions There is increasing recognition of frailty in nephrology populations and the value of assessment in informing prognostication and decision-making during transitions in care. The Fried Frailty Phenotype is frequently utilised and offers comparison of frailty prevalence and outcomes over different research settings, as well as offering the opportunity to define a pre-frail state. Further research examining frailty in culturally and linguistically diverse populations is required. Future work should focus on interventional strategies exploring frailty rehabilitation.
- Open Access
- 3 June 2022
- Published by Wiley in Internal Medicine Journal
- Vol. 52 (11) , 1900-1909
Equity and diversity in the nephrology workforce in Australia and New Zealand
Background: Despite diversity initiatives, inequities persist in medicine with negative implications for the workforce and patients. Little is known about workplace inequity in nephrology.Aim: To describe perceptions and experiences of bias by health professionals in the Australian and New Zealand Society of Nephrology (ANZSN), focussing on gender and race.Methods: A web‐based survey of ANZSN members recorded degree of perceived inequity on a Likert scale, ranging from 1 (none) to 5 (complete). Groups were compared using Mann–Whitney U‐test and logistic regression. Comments were synthesised using qualitative methods to explore themes of inequity and pathways to an inclusive future.Results: Of the 620 members of the ANZSN, there were 134 (22%) respondents, of whom 57% were women and 67% were White. The majority (88%) perceived inequities in the workforce. Perceived drivers of inequity were gender (84/113; 75%), carer responsibilities (74/113; 65%) and race (64/113; 56%). Half (74/131) had personally experienced inequity, based on gender in 70% (52/74) and race in 39% (29/75) with perceived discrimination coming from doctors, patients, academics and health administrators. White males were least likely (odds ratio 0.39; 95% confidence interval 0.18–0.90) to experience inequity. Dominant themes from qualitative analysis indicated that the major impacts of inequity were limited opportunities for advancement and lack of formal assistance for those experiencing inequities. Proposed solutions to reduce inequity included normalising the discourse on inequity at an organisational level, with policy changes to ensure diverse representation on committees and in executive leadership positions.Conclusions: Inequity, particularly driven by gender and race, is common for nephrology health professionals in Australia and New Zealand and impacts career progression.
- 3 June 2022
- Published by Wiley in Internal Medicine Journal
- Vol. 52 (11) , 1900-1909
Open AccessEquity and diversity in the nephrology workforce in Australia and New Zealand
Background: Despite diversity initiatives, inequities persist in medicine with negative implications for the workforce and patients. Little is known about workplace inequity in nephrology.Aim: To describe perceptions and experiences of bias by health professionals in the Australian and New Zealand Society of Nephrology (ANZSN), focussing on gender and race.Methods: A web‐based survey of ANZSN members recorded degree of perceived inequity on a Likert scale, ranging from 1 (none) to 5 (complete). Groups were compared using Mann–Whitney U‐test and logistic regression. Comments were synthesised using qualitative methods to explore themes of inequity and pathways to an inclusive future.Results: Of the 620 members of the ANZSN, there were 134 (22%) respondents, of whom 57% were women and 67% were White. The majority (88%) perceived inequities in the workforce. Perceived drivers of inequity were gender (84/113; 75%), carer responsibilities (74/113; 65%) and race (64/113; 56%). Half (74/131) had personally experienced inequity, based on gender in 70% (52/74) and race in 39% (29/75) with perceived discrimination coming from doctors, patients, academics and health administrators. White males were least likely (odds ratio 0.39; 95% confidence interval 0.18–0.90) to experience inequity. Dominant themes from qualitative analysis indicated that the major impacts of inequity were limited opportunities for advancement and lack of formal assistance for those experiencing inequities. Proposed solutions to reduce inequity included normalising the discourse on inequity at an organisational level, with policy changes to ensure diverse representation on committees and in executive leadership positions.Conclusions: Inequity, particularly driven by gender and race, is common for nephrology health professionals in Australia and New Zealand and impacts career progression.
- Open Access
- 30 May 2022
- Published by Wiley in Internal Medicine Journal
- Vol. 53 (4) , 465-472
Frailty in chronic kidney disease: challenges in nephrology practice. A review of current literature
Frailty is a multidimensional clinical syndrome characterised by low physical activity, reduced strength, accumulation of multi‐organ deficits, decreased physiological reserve and vulnerability to stressors. Frailty pathogenesis and ‘inflammageing’ is augmented by uraemia, leading to a high prevalence of frailty potentially contributing to adverse outcomes in patients with advanced chronic kidney disease (CKD), including end‐stage kidney disease (ESKD). The presence of frailty is a stronger predictor of CKD outcomes than estimated glomerular filtration rate and more aligned with dialysis outcomes than age. Frailty assessment should form part of routine assessment of patients with CKD and inform key medical transitions. Frailty screening and interventions in CKD/ESKD should be a research priority.
- 30 May 2022
- Published by Wiley in Internal Medicine Journal
- Vol. 53 (4) , 465-472
Open AccessFrailty in chronic kidney disease: challenges in nephrology practice. A review of current literature
Frailty is a multidimensional clinical syndrome characterised by low physical activity, reduced strength, accumulation of multi‐organ deficits, decreased physiological reserve and vulnerability to stressors. Frailty pathogenesis and ‘inflammageing’ is augmented by uraemia, leading to a high prevalence of frailty potentially contributing to adverse outcomes in patients with advanced chronic kidney disease (CKD), including end‐stage kidney disease (ESKD). The presence of frailty is a stronger predictor of CKD outcomes than estimated glomerular filtration rate and more aligned with dialysis outcomes than age. Frailty assessment should form part of routine assessment of patients with CKD and inform key medical transitions. Frailty screening and interventions in CKD/ESKD should be a research priority.
- 15 November 2021
- Published by Wiley in Internal Medicine Journal
- Vol. 53 (4) , 590-598
Attitudes, practices and experiences of medical specialists towards email communication with their patients
Background The medical profession has been slow in embracing email as a means of improving communication with patients. Aim To explore the attitudes, practices, and experiences of senior medical specialists towards email communication with their patients. Methods A cross-sectional qualitative interview of 30 medical staff specialists employed by Canberra Health Services, administered via one-on-one interviews conducted between June and August 2020 (several months into the COVID-19 pandemic). Main outcome measures Comments extracted from the interviews were categorised into five domains: (1) Integration of email use with patients, (2) Issues addressed via email, (3) Benefits of email communication, (4) Concerns and barriers to email communication, and (5) Practice pointers for email use with patients. Results Regular email correspondence with patients was not widespread. The main benefits identified were improved efficiency and flexibility, especially in the context of managing chronic disease and patient follow-up. Participants also identified barriers, including time commitments, privacy and confidentiality, patient expectations, and potential for misuse. Most participants were hesitant to endorse email with patients in their practices, citing concerns over the utility and safety of the medium and lack of established protocols and recommendations for email usage. Conclusions There is a want and need for comprehensive and accessible professional guidance on email use with patients. Our results indicate opportunities to inform good clinical practice in respect of doctor-patient relationships, clinical workloads, and risk management. There is also a need for formal guidelines on emailing with patients. The COVID-19 pandemic has heightened the need for such guidelines.
- 15 November 2021
- Published by Wiley in Internal Medicine Journal
- Vol. 53 (4) , 590-598
Attitudes, practices and experiences of medical specialists towards email communication with their patients
Background The medical profession has been slow in embracing email as a means of improving communication with patients. Aim To explore the attitudes, practices, and experiences of senior medical specialists towards email communication with their patients. Methods A cross-sectional qualitative interview of 30 medical staff specialists employed by Canberra Health Services, administered via one-on-one interviews conducted between June and August 2020 (several months into the COVID-19 pandemic). Main outcome measures Comments extracted from the interviews were categorised into five domains: (1) Integration of email use with patients, (2) Issues addressed via email, (3) Benefits of email communication, (4) Concerns and barriers to email communication, and (5) Practice pointers for email use with patients. Results Regular email correspondence with patients was not widespread. The main benefits identified were improved efficiency and flexibility, especially in the context of managing chronic disease and patient follow-up. Participants also identified barriers, including time commitments, privacy and confidentiality, patient expectations, and potential for misuse. Most participants were hesitant to endorse email with patients in their practices, citing concerns over the utility and safety of the medium and lack of established protocols and recommendations for email usage. Conclusions There is a want and need for comprehensive and accessible professional guidance on email use with patients. Our results indicate opportunities to inform good clinical practice in respect of doctor-patient relationships, clinical workloads, and risk management. There is also a need for formal guidelines on emailing with patients. The COVID-19 pandemic has heightened the need for such guidelines.